Thus, all of these results indicate that ANKFN1 promotes HCC cell proliferation and apoptosis via the MEK/ERK/c-Myc/cyclin D1/Cdk4/Cdk6 pathway. Here, MAPK1 is linked to hepatocellular carcinoma.